Table 3.
Financial Strain and Quality of Life in Breast Cancer
| Financial Strain Absent (n=193) |
Financial Strain Present (n=116) |
|||||
|---|---|---|---|---|---|---|
| Quality of Life Measures | M | (SD) | M | (SD) | Standardized Mean Difference (Cohen’s d) |
p |
| Sample 1 (N=55) | n=32 | n=23 | ||||
| Emotional | ||||||
| Depression Symptom Severity (DASS) | 2.81 | (2.83) | 5.35 | (4.03) | 0.77 | .008 |
| Anxiety Symptom Severity (DASS) | 2.19 | (2.75) | 3.09 | (2.56) | 0.32 | .253 |
| Physical | ||||||
| Perceived Health (SF-1) | 3.53 | (1.08) | 3.04 | (0.77) | 0.74 | .011 |
| Physical Symptom Burden (FACT-G) | 1.08 | (0.91) | 1.61 | (0.98) | 0.50 | .080 |
| Sample 2 (N = 120) | n=84 | n=36 | ||||
| Emotional | ||||||
| Depression Symptom Severity (PROMIS) | 2.18 | (2.81) | 5.00 | (3.93) | 0.85 | <.001 |
| Physical | ||||||
| Perceived Health (SF-1) | 3.54 | (0.87) | 2.97 | (0.97) | 0.50 | .021 |
| Physical Symptom Burden (FACT-G) | 0.55 | (0.65) | 1.21 | (0.94) | 0.80 | <.001 |
| Sample 3 (N = 134) | ||||||
| Emotional | n=77 | n=57 | ||||
| Depression Symptom Severity (PROMIS) | 1.62 | (2.80) | 3.91 | (3.84) | 0.53 | .004 |
| Anxiety Symptom Severity (PROMIS) | 2.57 | (2.82) | 5.49 | (4.48) | 0.59 | .002 |
| Physical | ||||||
| Perceived Health (SF-1) | 3.49 | (0.96) | 2.81 | (0.90) | 0.56 | .003 |
| Physical Symptom Burden (FACT-G) | 0.55 | (0.65) | 1.22 | (0.94) | 0.66 | <.001 |
Note. DASS = Depression Anxiety Stress Scale (summated score for depression and anxiety computed from 7 items rated from 0–3) [22]. SF-1 = first item from the Short Form Health Survey (rated from 1–5) [26]. FACT-G = Functional Assessment of Cancer Therapy - General (mean composite of 7 symptom items rated from 0–4) [27]. PROMIS = Patient Reported Outcome Measurement Information System (summated score for depression and anxiety computed from 4 items rated from 0–4) [25]. Financial strain in each sample was assessed using a four-item checklist [3]. Means and standard deviations are unadjusted for covariates. The standardized mean difference and significant test control for age, education level, presence/absence of metastases, and time since diagnosis.